We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCII icon
3151
LCI Industries
LCII
$2.56B
$30K ﹤0.01%
289
-3,473
-92% -$435K
MRAM icon
3152
Everspin Technologies
MRAM
$454M
$30K ﹤0.01%
3,378
-8,234
-71% -$78.8K
NRIX icon
3153
Nurix Therapeutics
NRIX
$2.8B
$30K ﹤0.01%
2,126
-2,559
-55% -$45.4K
ORN icon
3154
Orion Group Holdings
ORN
$401M
$30K ﹤0.01%
12,224
+7,443
+156% +$22.7K
PHR icon
3155
Phreesia
PHR
$761M
$30K ﹤0.01%
1,150
-6,365
-85% -$195K
RDN icon
3156
Radian Group
RDN
$4.95B
$30K ﹤0.01%
1,345
-981
-42% -$22.6K
RSI icon
3157
Rush Street Interactive
RSI
$2.94B
$30K ﹤0.01%
4,121
+2,067
+101% +$20.8K
SHO icon
3158
Sunstone Hotel Investors
SHO
$2.03B
$30K ﹤0.01%
2,529
+511
+25% +$5.8K
TWO
3159
Two Harbors Investment
TWO
$1.26B
$30K ﹤0.01%
1,320
-4,578
-78% -$99.5K
VCYT icon
3160
Veracyte
VCYT
$3.35B
$30K ﹤0.01%
1,090
+421
+63% +$12K
VSEC icon
3161
VSE Corp
VSEC
$6.73B
$30K ﹤0.01%
657
+457
+229% +$22.8K
WKHS icon
3162
Workhorse Group
WKHS
$32.8M
$30K ﹤0.01%
2
+1
+100% +$11K
XLO icon
3163
Xilio Therapeutics
XLO
$60.3M
$30K ﹤0.01%
307
+238
+345% +$37.7K
ABCM
3164
DELISTED
Abcam PLC
ABCM
$30K ﹤0.01%
1,680
+320
+24% +$5.67K
CVET
3165
DELISTED
Covetrus, Inc. Common Stock
CVET
$30K ﹤0.01%
1,815
+888
+96% +$15.5K
EPZM
3166
DELISTED
Epizyme, Inc
EPZM
$30K ﹤0.01%
26,095
-2,508
-9% -$4.09K
ARTEU
3167
DELISTED
Artemis Strategic Investment Corporation Unit
ARTEU
$30K ﹤0.01%
2,983
-105
-3% -$1.06K
INBX
3168
DELISTED
Inhibrx, Inc. Common Stock
INBX
$30K ﹤0.01%
1,360
-808
-37% -$20.6K
APEI icon
3169
American Public Education
APEI
$818M
$29K ﹤0.01%
1,352
-11,236
-89% -$237K
ARVN icon
3170
Arvinas
ARVN
$580M
$29K ﹤0.01%
427
-193
-31% -$13.2K
ASPS icon
3171
Altisource Portfolio Solutions
ASPS
$64.6M
$29K ﹤0.01%
301
+266
+760% +$24.4K
AVDL
3172
DELISTED
Avadel Pharmaceuticals
AVDL
$29K ﹤0.01%
4,191
-15,579
-79% -$107K
AXDX
3173
DELISTED
Accelerate Diagnostics
AXDX
$29K ﹤0.01%
2,006
+1,637
+444% +$46.6K
BRKL
3174
DELISTED
Brookline Bancorp
BRKL
$29K ﹤0.01%
1,810
+871
+93% +$14.7K
CASH icon
3175
Pathward Financial
CASH
$1.8B
$29K ﹤0.01%
523
-104
-17% -$5.91K
125 126
127
128 129

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.